Summary. The biological properties of three covalently-linked insulin dimers were studied in greyhounds. Constant infusions showed that the plasma distribution kinetics were slower for the dimers than for insulin. The metabolic clearance rates of the three dimers (10.3 _+ 0.4, 8.8 _+ 0.5, 8.2_+ 0.5 ml. min-1. kg-~; mean + SEM) were significantly lower than that of insulin (19 + 0.8 ml. rain-i. kg-~), and their hypoglycaemic effects (11.2%, 3% and 0.3%) were markedly reduced compared with their lipogenic potencies in vitro (80%, 30% and 13%, respectively). A low dose infusion of insulin or an equipotent dose of one of the dimers significantly prolonged the effects of an insulin bolus on plasma glucose but not on non-esterified fatty acids. The apparent distribution space (106.4-+11.9 ml/kg) and clearance rate (14.7 _+ 0.5 ml. min-1 kg-1) of an insulin bolus were significantly reduced by one dimer (44.5 _ 8.4 ml/ kg and 10.7 _ 2.8 ml. min-1, kg-1) but not by the equipotent insulin infusion (102.7_8.2ml/kg and 16.4_+ 0.07ml. min-1, kg-~). The apparent partial competitive antagonism of insulin by the dimers that has been reported in vitro can be observed in vivo, in that antagonism of insulin metabolism was directly demonstrated with one of the dimers.Key words: Chemically-modified insulins, insulin structurefunction, bioactivity and metabolism in vivo, competitive antagonism, hypoglycaemia, non-esterified fatty acids.For chemically-modified monomeric insulins close correlations have been reported between biological properties in vivo and receptor binding affinities or biochemical responses in vitro [1]. Moreover, insulin derivatives with modifications in or near the putative receptor binding region (A1,5,19,21 and B12,16,22-26) [2,3] exhibited parallel reductions in their rates of metabolism and hypoglycaemic potencies, whereas those insulins modified at other residues, such as at B1 or B29, retained full or nearly full metabolism and biological expressions [4]. These studies suggest highly specific structural requirements for insulin metabolism and action.We have previously reported that covalently-linked insulin dimers possessed unusual properties in vitro. In particular, their binding affinities for insulin receptors in various tissues were markedly higher than their lipogenic or anti-lipolytic potencies in isolated rat adipocytes [5,6]. We have now studied three dimers in greyhounds to determine the physiological implications of these unusual features. Since the observations in vitro suggested that the dimers behaved as partial antagonists of insulin, this aspect was also investigated directly in vivo with one of the dimers.
Materials and methodsThree covalently-linked insulin dimers were prepared and kindly donated by Drs. A. Schfittler and D. Brandenburg, Deutsches Wollforschungsinstitut, Aachen, FRG [7] (N m, NB'2%suberoyl-insulin dimer (B1-B'29 D), N m, BB'l-suberoyl-insulin dimer (B1-B'I D), and N B29, NB'29-suberoyl-insulin dimer (B29-B'29 D)). Highly purified bovine insulin was supplied by the same gr...